These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 35732250)

  • 41. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stem cell membrane-camouflaged targeted delivery system in tumor.
    Zhang W; Huang X
    Mater Today Bio; 2022 Dec; 16():100377. PubMed ID: 35967738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
    Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
    J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in biomimetic nanomaterial delivery systems: harnessing nature's inspiration for targeted drug delivery.
    Kang W; Xu Z; Lu H; Liu S; Li J; Ding C; Lu Y
    J Mater Chem B; 2024 Jul; 12(29):7001-7019. PubMed ID: 38919030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineered Exosomes as Theranostic Platforms for Cancer Treatment.
    Yang X; Xie X; Liu S; Ma W; Zheng Z; Wei H; Yu CY
    ACS Biomater Sci Eng; 2023 Oct; 9(10):5479-5503. PubMed ID: 37695590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aptamer-guided extracellular vesicle theranostics in oncology.
    Tran PH; Xiang D; Nguyen TN; Tran TT; Chen Q; Yin W; Zhang Y; Kong L; Duan A; Chen K; Sun M; Li Y; Hou Y; Zhu Y; Ma Y; Jiang G; Duan W
    Theranostics; 2020; 10(9):3849-3866. PubMed ID: 32226524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exosome-based delivery nanoplatforms: next-generation theranostic platforms for breast cancer.
    Zheng Y; Li M; Weng B; Mao H; Zhao J
    Biomater Sci; 2022 Mar; 10(7):1607-1625. PubMed ID: 35188522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment.
    Chan MH; Chang ZX; Huang CF; Lee LJ; Liu RS; Hsiao M
    Nanoscale Horiz; 2022 Mar; 7(4):352-367. PubMed ID: 35043812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stem Cell-Derived Exosomes: An Advanced Horizon to Cancer Regenerative Medicine.
    Ramachandran A; Dhar R; Devi A
    ACS Appl Bio Mater; 2024 Apr; 7(4):2128-2139. PubMed ID: 38568170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical failure of nanoparticles in cancer: mimicking nature's solutions.
    Hernández-Camarero P; Amezcua-Hernández V; Jiménez G; García MA; Marchal JA; Perán M
    Nanomedicine (Lond); 2020 Aug; 15(23):2311-2324. PubMed ID: 32969312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Research Progress in Bioinspired Drug Delivery Systems.
    Tong Q; Qiu N; Ji J; Ye L; Zhai G
    Expert Opin Drug Deliv; 2020 Sep; 17(9):1269-1288. PubMed ID: 32543953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics.
    Kar R; Dhar R; Mukherjee S; Nag S; Gorai S; Mukerjee N; Mukherjee D; Vatsa R; Chandrakanth Jadhav M; Ghosh A; Devi A; Krishnan A; Thorat ND
    ACS Biomater Sci Eng; 2023 Feb; 9(2):577-594. PubMed ID: 36621949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice.
    Gao C; Wang Y; Sun J; Han Y; Gong W; Li Y; Feng Y; Wang H; Yang M; Li Z; Yang Y; Gao C
    Acta Biomater; 2020 May; 108():285-299. PubMed ID: 32251785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
    Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
    Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ROS-responsive biomimetic nanosystem camouflaged by hybrid membranes of platelet-exosomes engineered with neuronal targeting peptide for TBI therapy.
    Li Y; Xin X; Zhou X; Liu J; Liu H; Yuan S; Liu H; Hao W; Sun J; Wang Y; Gong W; Yang M; Li Z; Han Y; Gao C; Yang Y
    J Control Release; 2024 Aug; 372():531-550. PubMed ID: 38851535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization.
    Dehaini D; Wei X; Fang RH; Masson S; Angsantikul P; Luk BT; Zhang Y; Ying M; Jiang Y; Kroll AV; Gao W; Zhang L
    Adv Mater; 2017 Apr; 29(16):. PubMed ID: 28199033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
    Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
    Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smart Nanocarriers for Targeted Cancer Therapy.
    Martinelli C
    Anticancer Agents Med Chem; 2021; 21(5):546-557. PubMed ID: 32560615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.